In comparison to C3 and C4, where levels represent the net rate of production and consumption, this assay measures a cleavage neoepitope solely exposed during complement activation and it has proven valuable as a biomarker in another autoimmune disease [35, 36]. The gene discussed is C4A; the disease is autoimmune disease.